An activin receptor IIA ligand trap corrects ineffective erythropoiesis in β-thalassemia. - Wikidata - awgldk - TriplyDB

An activin receptor IIA ligand trap corrects ineffective erythropoiesis in β-thalassemia.

An activin receptor IIA ligand trap corrects ineffective erythropoiesis in β-thalassemia.

http://www.wikidata.org/entity/Q35127943

about

Hepcidin: A Promising Therapeutic Target for Iron Disorders: A Systematic Review Profile of deferasirox for the treatment of patients with non-transfusion-dependent thalassemia syndromes Oxidative stress in β-thalassaemia and sickle cell disease New insights into iron regulation and erythropoiesis Anemia: progress in molecular mechanisms and therapies β-thalassemias: paradigmatic diseases for scientific discoveries and development of innovative therapies The Interplay Between Peroxiredoxin-2 and Nuclear Factor-Erythroid 2 Is Important in Limiting Oxidative Mediated Dysfunction in β-Thalassemic Erythropoiesis Recent advances in the understanding of myelodysplastic syndromes with ring sideroblasts.Iron overload induced death of osteoblasts in vitro: involvement of the mitochondrial apoptotic pathway.Molecular liaisons between erythropoiesis and iron metabolism A phase 1 study of ACE-536, a regulator of erythroid differentiation, in healthy volunteers.BMP type II receptors have redundant roles in the regulation of hepatic hepcidin gene expression and iron metabolism Biochemistry and Biology of GDF11 and Myostatin: Similarities, Differences, and Questions for Future Investigation RAP-011, an activin receptor ligand trap, increases hemoglobin concentration in hepcidin transgenic mice Concise review: hematopoietic stem cell aging and the prospects for rejuvenation Myelodysplasia is in the niche: novel concepts and emerging therapies.Development of novel activin-targeted therapeutics.Emerging EPO and EPO receptor regulators and signal transducers.Dysregulation of the Transforming Growth Factor β Pathway in Induced Pluripotent Stem Cells Generated from Patients with Diamond Blackfan Anemia.Impact of iron overload and potential benefit from iron chelation in low-risk myelodysplastic syndrome A comprehensive joint analysis of the long and short RNA transcriptomes of human erythrocytes.SF3B1 mutation identifies a distinct subset of myelodysplastic syndrome with ring sideroblasts.Sotatercept (ACE-011) for the treatment of chemotherapy-induced anemia in patients with metastatic breast cancer or advanced or metastatic solid tumors treated with platinum-based chemotherapeutic regimens: results from two phase 2 studies.Advances in understanding erythropoiesis: evolving perspectives Ligand trap for the activin type IIA receptor protects against vascular disease and renal fibrosis in mice with chronic kidney disease.Serum Levels of Growth Differentiation Factor 11 Are Independently Associated with Low Hemoglobin Values in Hemodialysis Patients GDF11 improves tubular regeneration after acute kidney injury in elderly mice.Iron overload across the spectrum of non-transfusion-dependent thalassaemias: role of erythropoiesis, splenectomy and transfusions.Iron age: novel targets for iron overload.Iron chelation therapy in transfusion-dependent thalassemia patients: current strategies and future directions.Experimental and investigational therapies for chemotherapy-induced anemia.Targeting EPO and EPO receptor pathways in anemia and dysregulated erythropoiesis.A complicated disease: what can be done to manage thalassemia major more effectively?Ineffective erythropoiesis and regulation of iron status in iron loading anaemias.Thalassemia 2016: Modern medicine battles an ancient disease.Novel therapeutic strategies in myelodysplastic syndromes: do molecular genetics help?Protein-based therapeutic for anemia caused by dyserythropoiesis.Investigational therapies for renal disease-induced anemia.Morbidities in non-transfusion-dependent thalassemia.Advances in understanding the mechanisms of erythropoiesis in homeostasis and disease.

P2860

Q26750731-9F2F1C66-9696-4DF7-AB49-D59AD10520C1 Q26771519-1935EA8D-1DB9-4634-B7B8-28B8F546EB0F Q26797178-2C667491-067A-4683-916F-D5516F49630A Q27009305-1E53597E-9D58-4C23-ACF2-E90D0653324C Q27023172-7EE80D1F-EEAD-4724-9AD6-78F6EA0903D8 Q28086960-CA60F533-D815-43C7-A98C-AA1351BA141C Q28396211-E036893C-A475-445A-84CC-E2A818DD0733 Q30249108-B3E5894D-8544-4EA8-8D27-AD2DBD92B5BA Q32186236-CD3C920E-A332-49B0-8796-41BCC02E63EB Q33948684-EE98A895-636F-4B51-95C4-936E41260733 Q34235483-CB56F027-BD7B-41FA-86DE-0BFE83FAA7B1 Q34293026-D38425E2-FA32-43F4-A1D4-08B1D4CD5A5A Q34520504-4A5AA927-18EE-4E7E-9E2B-A0FA7389BF82 Q34771518-F74D7846-3CC1-4F09-ABC5-BED1E3843F8E Q35001363-0BF4E9A0-32C3-46E2-AC00-2C6841A34CBB Q35059425-361C1BA2-7D99-4C4F-B212-6B753ADB1BC8 Q35153096-0404709D-2E49-4E33-A6BA-BB9278BB536F Q35692391-4A0C930E-A767-40E7-845B-961B632F125E Q35741406-D711EB36-F667-48E9-93D5-2C10C3465888 Q35743810-DB555930-275C-448B-A328-0E19E354D8BD Q35842890-7712D6BC-481B-4405-8B3E-1691410B5B7C Q35925679-A31965CB-AE7B-4A2D-88AA-1E19F03618B6 Q36615063-3AA5AD22-08D2-41D7-9C03-4AF886482467 Q36803829-031071F4-9771-4F81-848E-4C543ACD1DA8 Q36905955-5F9837A0-FE6A-42D5-81FC-8EABCD1D0E8B Q36987459-89812642-E7C7-4C49-A99F-635306FE3FE8 Q37310579-E3357305-0F83-4D71-AD49-4D23441DB3A6 Q37595987-294B6C10-7D07-47BB-B4EC-7A93760D5756 Q38361657-9E0946EE-5B08-411B-AFFF-FD9EF9E364B7 Q38540491-CBBA0752-E7CD-4B09-A01F-A3D777BA7B2B Q38584639-97AF7F07-8340-430B-81D7-341FD7F3479C Q38595266-5C32276B-3066-49D8-AD3D-D5C84B7B1C70 Q38607875-FB3406F6-6B7B-40C3-A305-999F33E9252D Q38613789-51A13174-7B37-463B-ACDC-B93C4B31B77D Q38625435-31A39052-20EF-413B-AD8D-CAA3EF7CFF72 Q38716306-BBA8F929-09D9-40C9-875A-3FDB239815C1 Q38818403-369333C6-8FC0-4B5F-ACC6-911650545C1B Q38819455-B645C90F-50DB-4D78-8D27-52CA371EF019 Q38836177-64D9969D-6E0B-4059-9591-92747962C19B Q38904398-869C7ECC-A66D-4F02-B388-E017B82D4EB4

P2860

An activin receptor IIA ligand trap corrects ineffective erythropoiesis in β-thalassemia.

http://www.wikidata.org/entity/Q35127943

description

2014 nî lūn-bûn

@nan

2014 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի մարտին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

An activin receptor IIA ligand trap corrects ineffective erythropoiesis in β-thalassemia.

@ast

An activin receptor IIA ligand trap corrects ineffective erythropoiesis in β-thalassemia.

@en

type

label

An activin receptor IIA ligand trap corrects ineffective erythropoiesis in β-thalassemia.

@ast

An activin receptor IIA ligand trap corrects ineffective erythropoiesis in β-thalassemia.

@en

prefLabel

An activin receptor IIA ligand trap corrects ineffective erythropoiesis in β-thalassemia.

@ast

An activin receptor IIA ligand trap corrects ineffective erythropoiesis in β-thalassemia.

@en

P1433

Q35127943-A99E8553-1DA7-4A93-97D5-2C9F198CBE08

P1476

Q35127943-DFFD626F-6147-4CC9-8F60-8E22C2946DD0

P2093

Q35127943-02A9C797-F149-4852-9E23-2C68E73F3753

Q35127943-09ACB432-1672-46EE-AFFF-6EB6BB3FF1AE

Q35127943-0E8C96D0-D288-49F0-BE58-87EE618A7ACB

Q35127943-1C0ACFB4-3F73-45B5-9C33-BBBAF8B37F1A

Q35127943-2C3039E0-E757-46F5-89DD-62DB20344A50

Q35127943-32BD7586-3E50-4EBD-835E-39EF557E869A

Q35127943-419CC118-EF23-4C19-A451-4F7D16F958B8

Q35127943-49C5C827-273D-4AEF-99F5-775588F7E373

Q35127943-6F9E3837-75A7-4B44-B66E-3632DBE1BCC2

Q35127943-7238E59E-153C-4EC5-8F72-C5492F182CB1

P2888

Q35127943-65F2AFC2-9B44-406B-BC77-6E45407C2438

P304

Q35127943-A0D98245-F8F6-41DB-82AA-F844628B03DC

P31

Q35127943-ABDB7717-CB63-48C2-ACE0-D4D539A2302D

P356

Q35127943-30EE16B6-334D-44A4-9485-1A9A652DA759

P407

Q35127943-BFEEA4B0-8C80-4B6A-92DD-14C6872F67D4

P433

Q35127943-8FAC9099-4771-4816-86EC-DCFF1F0AC5C2

P478

Q35127943-61A8888B-7570-4731-AA98-DDDAC6F9386F

P50

Q35127943-1AD65D03-3949-4169-8AEA-14F5D5A76751

Q35127943-761EA887-2593-422D-A3E2-99E55F5543AF

Q35127943-8F6A0E19-5DCD-4841-AB05-C438412A2187

Q35127943-9141EEEF-6407-456B-9EB1-4695F904F4D4

Q35127943-A4A05BE8-37FD-455C-92A8-411B0EC96CB4

Q35127943-F06F3FF9-7427-41A5-9921-75A12B4A50BF

P577

Q35127943-35FD6FE7-7165-490D-8DD6-2AFF1E362521

P6179

Q35127943-BAB991BA-688F-42C9-AE63-ED41997D3B1A

P698

Q35127943-263D6756-3D74-41B7-B06B-B4E90473F6D5

P356

P1433

Nature Medicine

P1476

An activin receptor IIA ligand trap corrects ineffective erythropoiesis in β-thalassemia.

@en

P2093

Aurélie Fricot

http://www.w3.org/2001/XMLSchema#string

Céline Chartier

http://www.w3.org/2001/XMLSchema#string

Damien Grapton

http://www.w3.org/2001/XMLSchema#string

Etienne Paubelle

http://www.w3.org/2001/XMLSchema#string

Francine Coté

http://www.w3.org/2001/XMLSchema#string

Jean-Antoine Ribeil

http://www.w3.org/2001/XMLSchema#string

Jean-Benoit Arlet

http://www.w3.org/2001/XMLSchema#string

Joel Veiga

http://www.w3.org/2001/XMLSchema#string

Michael Dussiot

http://www.w3.org/2001/XMLSchema#string

Olivier Negre

http://www.w3.org/2001/XMLSchema#string

P2888

P304

398-407

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/NM.3468

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

20

http://www.w3.org/2001/XMLSchema#string

P50

Olivier Hermine

Thiago Trovati Maciel

P577

2014-03-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1050379042

http://www.w3.org/2001/XMLSchema#string

P698

24658077

http://www.w3.org/2001/XMLSchema#string